Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.58% | 53.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.58% | 53.87% | |||
| Cost of Revenue | 20.90% | 14.56% | |||
| Gross Profit | 5.61% | 97.11% | |||
| SG&A Expenses | -10.58% | 54.01% | |||
| Depreciation & Amortization | 1,481.25% | 6.67% | |||
| Other Operating Expenses | -- | -39.01% | |||
| Total Operating Expenses | -9.44% | 18.66% | |||
| Operating Income | 87.40% | 35.85% | |||
| Income Before Tax | 80.83% | 35.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 80.83% | 35.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 80.83% | 35.91% | |||
| EBIT | 87.40% | 35.85% | |||
| EBITDA | 100.80% | 36.03% | |||
| EPS Basic | -92.17% | 35.39% | |||
| Normalized Basic EPS | -91.67% | 35.14% | |||
| EPS Diluted | -92.17% | 35.39% | |||
| Normalized Diluted EPS | -91.67% | 35.14% | |||
| Average Basic Shares Outstanding | -90.01% | -0.87% | |||
| Average Diluted Shares Outstanding | -90.01% | -0.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||